Why I think these expensive shares could be great value

The CSL Limited (ASX:CSL) share price is one of two which look expensive but could prove to be great value in the long-term…

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Although the high multiples that some growth shares trade at can be off-putting for many investors, I believe that strong market positions and growth prospects can make it worth paying a premium to own certain shares.

Two top growth shares which I think are great buy and hold investments at their current share prices are listed below. Here's why I like them:

CSL Limited (ASX: CSL)

As one of Australia's leading companies I believe CSL is worthy of trading at a premium over the market average. Although at present the biotherapeutics company's shares are changing hands at approximately 38x trailing earnings, it is worth noting that CSL expenses its substantial research and development costs rather than capitalising them. If these costs were capitalised then earnings per share would be significantly higher. But regardless of this, I believe its core business and soon-to-be-profitable Seqirus influenza business put it in a position to deliver above-average earnings growth over the next few years.

Nextdc Ltd ASX: NXT

As one of the world's leading data centre operators, I think that NEXTDC is one of the best long-term buy and hold investment options on the market today thanks to the rise of cloud computing. Companies including the likes of Google and Amazon are amongst its customers and it isn't hard to see why when its recently opened data centres have the highest level of accreditation available. While its shares look incredibly expensive at 134x estimated forward earnings, I believe the company will more than grow into its valuation as it scales. Earnings growth in FY 2018 is expected to slow due to the investments it has made, before accelerating greatly again in FY 2019. But considering its sky high multiple, it is potentially only suitable for those with a high tolerance for risk.

Motley Fool contributor James Mickleboro owns shares of NEXTDC Limited. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »